US5866363A
(en)
|
1985-08-28 |
1999-02-02 |
Pieczenik; George |
Method and means for sorting and identifying biological information
|
US5744101A
(en)
|
1989-06-07 |
1998-04-28 |
Affymax Technologies N.V. |
Photolabile nucleoside protecting groups
|
US20030225254A1
(en)
*
|
1989-08-07 |
2003-12-04 |
Rathjen Deborah Ann |
Tumour necrosis factor binding ligands
|
US5959087A
(en)
*
|
1989-08-07 |
1999-09-28 |
Peptide Technology, Ltd. |
Tumour necrosis factor binding ligands
|
EP0486526B2
(de)
*
|
1989-08-07 |
2001-03-07 |
Peptech Limited |
Bindeligande für tumornekrosisfaktor
|
DE3935572A1
(de)
*
|
1989-10-25 |
1991-05-02 |
Biotechnolog Forschung Gmbh |
Verfahren zur peptidsynthese und traeger dafuer
|
AU1248292A
(en)
|
1990-12-06 |
1992-07-08 |
Affymax Technologies N.V. |
Sequencing by hybridization of a target nucleic acid to a matrix of defined oligonucleotides
|
US20010021513A1
(en)
*
|
1991-11-21 |
2001-09-13 |
Puijk Wouter Cornelis |
Test device comprising a plate containing a multiplicity of wells with an associated metering device, as well as a kit which comprises these devices and use of the devices
|
DE59209745D1
(de)
*
|
1991-11-29 |
1999-10-21 |
Hoechst Ag |
Peptide mit insulinartiger Wirkung
|
MX9304388A
(es)
*
|
1992-07-22 |
1994-03-31 |
Proteus Molecular Design |
Polopeptido sintetico y proceso para su fabricacion.
|
US5702672A
(en)
*
|
1992-10-08 |
1997-12-30 |
Warner-Lambert Company |
Apparatus and method for multiple simultaneous synthesis
|
US5714127A
(en)
*
|
1992-10-08 |
1998-02-03 |
Warner-Lambert Company |
System for multiple simultaneous synthesis
|
US5567391A
(en)
*
|
1992-10-08 |
1996-10-22 |
Warner-Lambert Company |
Apparatus for multiple simultaneous synthesis
|
US5324483B1
(en)
*
|
1992-10-08 |
1996-09-24 |
Warner Lambert Co |
Apparatus for multiple simultaneous synthesis
|
AU680450B2
(en)
*
|
1992-11-06 |
1997-07-31 |
Mimotopes Pty Ltd |
Support for the synthesis of modular polymers
|
NZ268292A
(en)
*
|
1993-06-21 |
1997-09-22 |
Selectide Corp |
Solid phase peptide synthesis and supports therefor
|
US5380668A
(en)
*
|
1993-07-06 |
1995-01-10 |
University Of Utah Research Foundation |
Compounds having the antigenicity of hCG
|
CA2208693A1
(en)
*
|
1994-12-30 |
1996-07-11 |
Chiron Corporation |
Method for the controlled synthesis of polynucleotide mixtures which encode desired mixtures of peptides
|
US5958792A
(en)
*
|
1995-06-07 |
1999-09-28 |
Chiron Corporation |
Combinatorial libraries of substrate-bound cyclic organic compounds
|
WO1997012897A1
(en)
*
|
1995-10-03 |
1997-04-10 |
The Penn State Research Foundation |
Method to identify a surface-bound molecule
|
US7517952B1
(en)
*
|
1997-02-25 |
2009-04-14 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US20060269532A1
(en)
*
|
1997-02-25 |
2006-11-30 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US20060024301A1
(en)
*
|
1997-02-25 |
2006-02-02 |
Corixa Corporation |
Prostate-specific polypeptides and fusion polypeptides thereof
|
US20030185830A1
(en)
*
|
1997-02-25 |
2003-10-02 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
IL131162A0
(en)
*
|
1997-02-26 |
2001-01-28 |
Lilly Co Eli |
Selective epoxidation process for preparing pharmaceutical compounds
|
US7282198B2
(en)
*
|
1997-03-19 |
2007-10-16 |
The University Of Arkansas For Medical Sciences |
Immunotherapeutic methods targeted towards stratum corneum chymotryptic enzyme
|
US7335351B2
(en)
*
|
1997-03-19 |
2008-02-26 |
The University Of Arkansas For Medical Sciences |
Immunotherapeutic methods targeted towards stratum corneum chymotryptic enzyme
|
US6294344B1
(en)
*
|
1997-03-19 |
2001-09-25 |
The Board Of Trustees Of The University Of Arkansas |
Methods for the early diagnosis of ovarian cancer
|
US7084239B1
(en)
*
|
1997-10-08 |
2006-08-01 |
The United States Of America As Represented By The Department Of Health And Human Services |
Cancer peptides of NY-ESO-1/CAG-3
|
US20020061848A1
(en)
*
|
2000-07-20 |
2002-05-23 |
Ajay Bhatia |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
US6432409B1
(en)
*
|
1999-09-14 |
2002-08-13 |
Antigen Express, Inc. |
Hybrid peptides modulate the immune response
|
US9289487B2
(en)
*
|
1999-09-14 |
2016-03-22 |
Antigen Express, Inc. |
II-key/antigenic epitope hybrid peptide vaccines
|
US20030235594A1
(en)
*
|
1999-09-14 |
2003-12-25 |
Antigen Express, Inc. |
Ii-Key/antigenic epitope hybrid peptide vaccines
|
US6919187B2
(en)
*
|
2000-04-21 |
2005-07-19 |
Corixa Corporation |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
US6656700B2
(en)
|
2000-05-26 |
2003-12-02 |
Amersham Plc |
Isoforms of human pregnancy-associated protein-E
|
JP2004503673A
(ja)
*
|
2000-07-14 |
2004-02-05 |
ミモトープス・プロプライエタリー・リミテッド |
活性化モジュラーグラフト重合表面
|
JP4503801B2
(ja)
*
|
2000-09-08 |
2010-07-14 |
独立行政法人科学技術振興機構 |
新規ヒト癌・精巣抗原及びその遺伝子
|
US20020123474A1
(en)
*
|
2000-10-04 |
2002-09-05 |
Shannon Mark E. |
Human GTP-Rho binding protein2
|
ATE520772T1
(de)
*
|
2000-10-31 |
2011-09-15 |
Eisai Inc |
Nucleinsäure kodierend für cyp1b1 und methoden zur verwendung
|
WO2002069907A2
(en)
*
|
2001-03-07 |
2002-09-12 |
Mannkind Corporation |
Anti-neovasculature preparations for cancer
|
US20040078837A1
(en)
*
|
2001-08-02 |
2004-04-22 |
Shannon Mark E. |
Four human zinc-finger-containing proteins: MDZ3, MDZ4, MDZ7 and MDZ12
|
AU2003213580A1
(en)
*
|
2002-02-26 |
2003-09-09 |
Genencor International, Inc. |
Subtilisin carlsberg proteins with reduced immunogenicity
|
WO2004016733A2
(en)
*
|
2002-08-16 |
2004-02-26 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
|
US7179645B2
(en)
*
|
2002-09-24 |
2007-02-20 |
Antigen Express, Inc. |
Ii-Key/antigenic epitope hybrid peptide vaccines
|
CA2499123A1
(en)
|
2002-09-17 |
2004-04-15 |
Antigen Express, Inc. |
Ii-key/antigenic epitope hybrid peptide vaccines
|
US6910785B2
(en)
*
|
2003-01-22 |
2005-06-28 |
Cooper Technologies Company |
Industrial luminaire with prismatic refractor
|
US20040185499A1
(en)
*
|
2003-03-20 |
2004-09-23 |
Jolley Michael E. |
Method of epitope scanning using fluorescence polarization
|
US20050095648A1
(en)
*
|
2003-10-30 |
2005-05-05 |
Mario Geysen |
Method for designing linear epitopes and algorithm therefor and polypeptide epitopes
|
AU2006273192B2
(en)
*
|
2005-07-27 |
2011-09-01 |
Oncotherapy Science, Inc. |
Colon cancer related gene TOM34
|
CA2628241C
(en)
|
2005-11-07 |
2016-02-02 |
Indiana University Research And Technology Corporation |
Glucagon analogs exhibiting physiological solubility and stability
|
SG177953A1
(en)
*
|
2007-01-05 |
2012-02-28 |
Univ Indiana Res & Tech Corp |
Glucagon analogs exhibiting enhanced solubility in physiological ph buffers
|
NZ578948A
(en)
|
2007-02-15 |
2012-03-30 |
Univ Indiana Res & Tech Corp |
Glucagon/glp-1 receptor co-agonists
|
EP2044949A1
(de)
|
2007-10-05 |
2009-04-08 |
Immutep |
Verwendung von rekombinantem LAG-3 oder Derivaten daraus zur Auslösung einer Monozyten-Immunreaktion
|
JP5771005B2
(ja)
*
|
2007-10-30 |
2015-08-26 |
インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションIndiana University Research And Technology Corporation |
グルカゴンアンタゴニスト及びglp−1アゴニスト活性を示す化合物
|
US8981047B2
(en)
|
2007-10-30 |
2015-03-17 |
Indiana University Research And Technology Corporation |
Glucagon antagonists
|
AU2009210570B2
(en)
*
|
2008-01-30 |
2014-11-20 |
Indiana University Research And Technology Corporation |
Ester-based insulin prodrugs
|
PE20100056A1
(es)
*
|
2008-06-17 |
2010-01-26 |
Univ Indiana Res & Tech Corp |
Analogos de glucagon como agonistas gip
|
AR072160A1
(es)
|
2008-06-17 |
2010-08-11 |
Univ Indiana Res & Tech Corp |
Co-agonistas del receptor de glucagon/glp-1
|
TWI541023B
(zh)
*
|
2008-06-17 |
2016-07-11 |
印第安納大學科技研究公司 |
在生理ph緩衝液中呈現增強之溶解度及穩定性之升糖激素類似物
|
JP2012512903A
(ja)
|
2008-12-19 |
2012-06-07 |
インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーション |
アミド系グルカゴンスーパーファミリーペプチドプロドラッグ
|
US20100310591A1
(en)
*
|
2009-01-28 |
2010-12-09 |
Robert Humphreys |
Ii-KEY HYBRID PEPTIDES THAT MODULATE THE IMMUNE RESPONSE TO INFLUENZA
|
IN2012DN00377A
(de)
|
2009-06-16 |
2015-08-21 |
Univ Indiana Res & Tech Corp |
|
US8703701B2
(en)
|
2009-12-18 |
2014-04-22 |
Indiana University Research And Technology Corporation |
Glucagon/GLP-1 receptor co-agonists
|
WO2011094337A1
(en)
|
2010-01-27 |
2011-08-04 |
Indiana University Research And Technology Corporation |
Glucagon antagonist - gip agonist conjugates and compositions for the treatment of metabolic disorders and obesity
|
MX2012013005A
(es)
|
2010-05-13 |
2013-02-26 |
Univ Indiana Res & Tech Corp |
Peptidos de la superfamilia de glucagon que presentan actividad del receptor acoplado a proteinas g.
|
JP6121323B2
(ja)
|
2010-05-13 |
2017-05-10 |
インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションIndiana University Research And Technology Corporation |
核内ホルモン受容体の活性を示すグルカゴンスーパーファミリーのペプチド
|
JP2013540102A
(ja)
|
2010-06-24 |
2013-10-31 |
インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーション |
アミド結合を介して修飾されたグルカゴンスーパーファミリーのペプチドプロドラッグ
|
CA2816175A1
(en)
|
2010-10-29 |
2012-05-03 |
Lonza Ltd |
Diketopiperazine forming dipeptidyl linker
|
AU2011336019B2
(en)
|
2010-12-02 |
2016-07-07 |
Oncotherapy Science, Inc. |
TOMM34 peptides and vaccines including the same
|
WO2012088116A2
(en)
|
2010-12-22 |
2012-06-28 |
Indiana University Research And Technology Corporation |
Glucagon analogs exhibiting gip receptor activity
|
PE20140724A1
(es)
|
2011-06-22 |
2014-07-10 |
Univ Indiana Res & Tech Corp |
Coagonistas del receptor de glucagon/glp-1
|
RU2014101697A
(ru)
|
2011-06-22 |
2015-07-27 |
Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн |
Коагонисты рецепторов глюкагона/glp-1
|
CA2847246A1
(en)
|
2011-11-17 |
2013-05-23 |
Indiana University Research And Technology Corporation |
Glucagon superfamily peptides exhibiting glucocorticoid receptor activity
|
EP2639299A1
(de)
*
|
2012-03-16 |
2013-09-18 |
Invectys |
Aus Telomerase abgeleitete, universelle Krebspeptide
|
JP6311708B2
(ja)
|
2012-06-21 |
2018-04-18 |
インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションIndiana University Research And Technology Corporation |
Gip受容体活性を示すグルカゴンアナローグ
|
AU2014241743B2
(en)
|
2013-03-14 |
2018-07-05 |
Indiana University Research And Technology Corporation |
Insulin-incretin conjugates
|
JP6479761B2
(ja)
|
2013-03-28 |
2019-03-06 |
アンヴェクティInvectys |
イヌ用がんワクチン
|
US9931387B2
(en)
|
2013-03-28 |
2018-04-03 |
Invectys |
Cancer vaccine for cats
|
NZ719098A
(en)
|
2013-10-28 |
2022-08-26 |
Invectys |
A telomerase encoding dna vaccine
|
EA035485B1
(ru)
|
2013-10-28 |
2020-06-24 |
Инвектис |
Электроперенос генов в клетки кожи
|
GB201322626D0
(en)
|
2013-12-19 |
2014-02-05 |
Immutep S A |
Combined preparations for the treatment of cancer
|
US9682123B2
(en)
|
2013-12-20 |
2017-06-20 |
The Trustees Of Columbia University In The City Of New York |
Methods of treating metabolic disease
|
US10232020B2
(en)
|
2014-09-24 |
2019-03-19 |
Indiana University Research And Technology Corporation |
Incretin-insulin conjugates
|
GB201500374D0
(en)
|
2015-01-09 |
2015-02-25 |
Immutep S A |
Combined preparations for the treatment of cancer
|
US11119104B2
(en)
|
2015-08-12 |
2021-09-14 |
The Trustees Of Columbia University In The City Of New York |
Methods of treating volume depletion and kidney injury
|
WO2018206512A1
(en)
|
2017-05-09 |
2018-11-15 |
Invectys |
Recombinant measles vaccine expressing htert
|